Nick Petty
Nick Petty
@npetty.bsky.social
PDX/PFL/SEA
E20 MSTP Student @ UWSOM
🩸🧠🦴
Reposted by Nick Petty
See you next week for Nick Petty’s ( @npetty.bsky.social ) defense!
Title: Replacement of microglia with hematopoietic stem cell-derived microglia-like cells in nonhuman primates & impact of CSF1R inhibitor treatment
Lab: Kiem Lab, FH
When: Wed, Nov 5, 3:30pm PST
Where: FH Pelton Auditorium & Zoom
October 29, 2025 at 10:30 PM
Reposted by Nick Petty
Join us for Nick Petty’s (@npetty.bsky.social ) dissertation defense!
Title: Replacement of microglia with hematopoietic stem cell-derived microglia-like cells in nonhuman primates & impact of CSF1R inhibitor treatment
Lab: Kiem Lab, FH
When: Wed, Nov 5, 3:30pm PST
Where: FH Pelton Auditorium & Zoom
October 22, 2025 at 10:30 PM
Reposted by Nick Petty
Spent the past few days visiting the @fredhutch.bsky.social to celebrate the impact of Dr. Rainer Storb on hematology & the thousands of patients living with blood disorders as the @ash.hematology.org Coulter Award winner.

Dr. Storb’s passion, curiosity, and persistence is so inspiring. #ASH25
July 17, 2025 at 2:01 AM
Reposted by Nick Petty
Nature reports how the Trump administration’s anti-mRNA sentiment has sparked fears that this once-celebrated technology, widely seen as a major engine of next-generation vaccines and therapeutics, could soon find itself on the chopping block. #medsky 🧪
How political attacks could crush the mRNA vaccine revolution
Drug makers are scrambling to navigate an ‘existential threat’ to a once-celebrated technology.
go.nature.com
May 22, 2025 at 1:12 AM
Reposted by Nick Petty
Researchers in Dr. Hans-Peter Kiem's lab at Fred Hutch devised a method that could one day treat genetic hematologic disorders by correcting how the body makes blood cells. Read more about their work, which they presented recently at #ASGCT2025. www.fredhutch.org/en/news/cent...
Gene therapy delivery system successfully targets CD90+ hematopoietic stem cells in vivo
Researchers in the lab of Hans-Peter Kiem, MD, PhD, at Fred Hutch Cancer Center have devised a method that could one day treat genetic hematologic disorders by correcting how the body makes blood cell...
www.fredhutch.org
May 20, 2025 at 10:46 PM
Reposted by Nick Petty
NEW: The NIH has begun terminating grants for active projects studying gender identity, DEI, environmental justice, climate change, among other topics.

At least 16 termination letters have already been sent — and hundreds more are coming, people inside NIH tell me.
www.nature.com/articles/d41...
Exclusive: NIH to terminate hundreds of active research grants
Studies that touch on LGBT+ health, gender identity and DEI in the biomedical workforce could be terminated, according to documents obtained by Nature.
www.nature.com
March 6, 2025 at 2:17 AM
Reposted by Nick Petty
"… it is the words and actions of all members of the scientific community … that form the collective voice of science …," writes @holdenthorp.bsky.social in a new #ScienceEditorial. scim.ag/4hR6ux0
February 24, 2025 at 7:08 PM
Reposted by Nick Petty
“There’s going to be a missing age class of researchers that will reverberate for years.” scim.ag/3ERRLDo
U.S. early-career researchers struggling amid chaos
Uncertain funding, government firings, and distressed universities hit vulnerable groups especially hard
scim.ag
February 24, 2025 at 2:59 PM
Happy to share a preprint for a forthcoming article in Blood Advances! I had the privilege to work with a super talented team here in Dr. Kiem's lab to contribute to the growing body of work showing safety and efficacy of CD33 CAR T cells for the treatment of AML.
Protection of CD33-modified hematopoietic stem cell progeny from CD33-directed CAR T cells in nonhuman primates
Key Points. The surface protein CD33 is amenable to multiple modes of editing without impact on hematopoietic cell reconstitution.CD33-directed CAR T cells
ashpublications.org
February 12, 2025 at 6:13 PM